Latest Video

Resverlogix has begun enrollment and dosing of patients in a Phase 2b clinical trial at a site at the University of Alberta Hospital in Edmonton, to evaluate the safety and efficacy of apabetalone as a potential oral treatment for COVID-19

Resverlogix has partnered with EVERSANA ™, a pioneer of next generation commercial services to the global life sciences industry, to support the rapid commercialization of apabetalone for COVID-19 in Canada and the United States.

Tags:

video news alert investmentpitch investmentpitch media business news financial news investments resverlogix corp apabetalone epigenetics gene regulation fda breakthrough therapy designation covid-19

Other Recent Videos

Tocvan releases Channel Samples including 19.8 meters of 0.73 g/t Au and 19.5 meters of 0.61 g/t Au at Pilar project in Sonora, Mexico	Platinex aquires the W2 copper-nickel-PGE project near Ring of Fire, northwestern Ontario	Gabe Frank, CEO of Arcade – NFT Marketplace & Liquidity \| Blockchain Interviews
New Listing: CopperCorp Resources (TSXV:CPER)	Bathurst Metals releases assays from 2021 field work in western Nunavut including 15.4% copper, 5.9% nickel, 1550 ppm cobalt, 4.06 ppm platinum and 44.5 ppm palladium	Endurance Gold reports the best gold intersection to date from a new drill discovery from its 2021 diamond drilling program at its Reliance Gold Property in southern British Columbia
Voyageur Pharmaceuticals announces PEA with NPV of $344 million and 137% IRR for Frances Creek Pharmaceutical Barium Project in BC	Parker McCurley, Co-Founder and CEO of Decent Labs \| Blockchain Interviews	Joseph Chong, Marketing & Strategic Partnerships at League of Ancients \| Blockchain Interviews
Investmentpitch Media video features Minto Metals, owner and operator of the producing Minto mine located in the Minto Copper Belt of the Yukon, Canada	New Listing: Volatus Aerospace Corp (TSXV:VOL)	New Listing: Reyna Gold Corp. (TSXV:REYG)

Featured

Resverlogix has begun enrollment and dosing of patients in a Phase 2b clinical trial at a site at the University of Alberta Hospital in Edmonton, to evaluate the safety and efficacy of apabetalone as a potential oral treatment for COVID-19

Bathurst Metals releases assays from 2021 field work in western Nunavut including 15.4% copper, 5.9% nickel, 1550 ppm cobalt, 4.06 ppm platinum and 44.5 ppm palladium

Investmentpitch Media video features Minto Metals, owner and operator of the producing Minto mine located in the Minto Copper Belt of the Yukon, Canada

Latest Video

Resverlogix has begun enrollment and dosing of patients in a Phase 2b clinical trial at a site at the University of Alberta Hospital in Edmonton, to evaluate the safety and efficacy of apabetalone as a potential oral treatment for COVID-19

Tags:

Categories

Other Recent Videos

Featured